Professor Nir Peled

A leading Israeli oncologist and pulmonologist. A top specialist in the diagnosis, early detection, treatment and prevention of lung cancer. He actively uses personalized targeted therapy, which in most cases gives excellent results. Professor Peled is among the top doctors in Israel in the international Forbes ranking.

• Faculty of Medicine, Technion. M.D., graduated with honors.
• Faculty of Medicine, Technion. Ph.D. in medicine.
• Beilinson Hospital. Residency in internal medicine, pulmonology and clinical oncology.
• University of Colorado Cancer Center (UCCC), Denver, USA. Fellowship in clinical oncology and thoracic oncology.
• Headed the Thoracic Cancer Research Center at Sheba Medical Center, Tel HaShomer.
• Headed the Thoracic Cancer Unit at the Davidoff Cancer Center, Beilinson Hospital.

Professor at the Department of Oncology, Faculty of Medicine, Tel Aviv University.
Professor of oncology at the Faculty of Medicine, Ben-Gurion University.

Professor Nir Peled is the author of more than 130 scientific articles.

• Since 2009: member of the Prevention, Screening and Early Detection Committee of the International Association for the Study of Lung Cancer (IASLC).
• Since 2013: chairman of the Prevention, Screening and Early Detection Committee of the IASLC.
• Since 2010: Clinical Medicine Opportunities: Practical Oncology, a continuing education program for physicians.
• Since 2011: member of the editorial board of a publication on pharmacotherapy of neoplastic diseases.
• Since 2012: scientific director of IRSUSAL01, an international study of the practical role of PET-CT, blood serum, sputum and breath tests in improving early diagnosis and cure rates of lung cancer (Israel-Florida collaboration).
• Since 2013: member of the thoracic oncology section of the European Respiratory Society.
• Chairman at the European Respiratory Society and of the international committee on early diagnosis of lung cancer.

• Diagnosis, treatment and prevention of lung cancer, including non-small cell lung cancer.
• Diagnosis of malignant diseases of the chest organs.
• Early diagnosis of lung cancer using biomarkers.
• Personalized targeted therapy of lung cancer.